Design and early progress of the Comparison of Anticoagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) trial
CAPTIVA is evaluating two alternative dual antithrombotic therapies to clopidogrel and aspirin to maximize the chance of establishing more effective antithrombotic therapy for symptomatic ICAS, one of the most common and high-risk cerebrovascular diseases worldwide.
Authors
- Jessica L. Smith (ORCID: https://orcid.org/0000-0002-2381-861X)
- Tanya N. Turan (ORCID: https://orcid.org/0000-0001-5399-8845)
- Renee Boyette
- Sharon D. Yeatts (ORCID: https://orcid.org/0000-0001-9235-0670)
- Noor Sabagha
- Ashley Wabnitz (ORCID: https://orcid.org/0000-0002-2191-6208)
- Brian Lim Hoh (ORCID: https://orcid.org/0000-0002-4997-4469)
- Jamey Frasure
- Lesley M. Butler
- Steve McLaren
- Clemens Unger (ORCID: https://orcid.org/0000-0003-0461-2488)
- Larisa H. Cavallari (ORCID: https://orcid.org/0000-0002-7184-5292)
- Marc I. Chimowitz (ORCID: https://orcid.org/0000-0001-5437-9245)
- Joseph P. Broderick (ORCID: https://orcid.org/0000-0002-7323-7709)
- Keith Peters (ORCID: https://orcid.org/0000-0002-6683-9111)
- Renee Martin
Institutions
- Medical University of South Carolina (US)
- University of Florida (US)
- University of Cincinnati (US)
Publication Details
- Journal
- International Journal of Stroke
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1177/17474930241313301
- Citations
- 4
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- AstraZeneca
- National Institute of Neurological Disorders and Stroke
- Janssen Pharmaceuticals